0001209191-19-026572.txt : 20190430
0001209191-19-026572.hdr.sgml : 20190430
20190430163357
ACCESSION NUMBER: 0001209191-19-026572
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190426
FILED AS OF DATE: 20190430
DATE AS OF CHANGE: 20190430
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Novak Alfred J
CENTRAL INDEX KEY: 0001388862
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38135
FILM NUMBER: 19782330
MAIL ADDRESS:
STREET 1: 325 NE 6TH ST
CITY: BOCA RATON
STATE: FL
ZIP: 33432
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dova Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001685071
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813858961
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 240 LEIGH FARM ROAD
CITY: DURHAM
STATE: NC
ZIP: 27707
BUSINESS PHONE: 919-806-4487
MAIL ADDRESS:
STREET 1: 240 LEIGH FARM ROAD
CITY: DURHAM
STATE: NC
ZIP: 27707
FORMER COMPANY:
FORMER CONFORMED NAME: Dova Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20160919
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-26
0
0001685071
Dova Pharmaceuticals Inc.
DOVA
0001388862
Novak Alfred J
C/O DOVA PHARMACEUTICALS, INC.
240 LEIGH FARM ROAD, SUITE 245
DURHAM
NC
27707
1
0
0
0
Stock Option (right to buy)
9.36
2019-04-26
4
A
0
10000
0.00
A
2029-04-25
Common Stock
10000
10000
D
Vesting monthly over one year from the grant date and in any event will be fully vested on the date of the next annual meeting of our stockholders, subject to continued service as a director though the applicable vesting date.
/s/ Mark Ballantyne, Attorney-in-Fact
2019-04-30